

Feb 26, 24 SMFM Position Statement RHIG < 12 Weeks: Confused?
Feb 26, 2024
Exploring the controversy surrounding RhoGAM administration to RH negative patients under 12 weeks gestational age. Insights into the shortage of RhoGAM and alternative products. Geographic disparities in access to blood products for RH factor in pregnancy. Debate on R-H-D testing and R-H-I-G administration in early pregnancies to prevent adverse outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Insight into the Rogam Immune Globulin Shortage and Market Dynamics
02:58 • 4min
RH Factor in Pregnancy Care and Geographic Variability in Access to Blood Products
06:35 • 3min
Controversy Surrounding R H Immune Globulin Provision After First-Trimester Abortion
09:10 • 5min
Debating R-H-D Testing and R-H-I-G Administration in Early Pregnancy
13:44 • 3min